Grieve, A.G. (2009) Study of the cell biological role of Lowe Syndrome protein OCRL1. Doctoral thesis, UCL (University College London).
|PDF - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader|
Oculocerebrorenal syndrome of Lowe (OCRL) is caused by mutations in a phosphatidylinositol 5-phosphatase, OCRL1, and is believed to lead to an elevation of its preferred substrate, PI(4,5)P2. To date, much of the work on OCRL1 has centred on its role at Golgi and endosomal membranes. However, there is also evidence of plasma membrane activity for OCRL1, where its PI(4,5)P2 substrate is known to be highly abundant. PI(4,5)P2 regulates a wide array of downstream cellular functions such as cytoskeletal dynamics, membrane trafficking and signalling. The tight regulation of PI(4,5)P2 levels and localisation, like other phosphoinositides, provides a framework upon which many of these cellular processes work. In this thesis, effects of OCRL1 loss have been tested through siRNA depletion of OCRL1, focussing where possible on multiple PI(4,5)P2-dependent mechanisms, and also focussing on cells forming polarised epithelia. Firstly, we have visualised the localisation of PI(4,5)P2 in living HeLa cells lacking OCRL1 through immunostaining for Annexin A2, which showed a marked translocation to the plasma membrane. This change in distribution of Annexin A2 suggested that OCRL1 depletion may have an effect on intracellular calcium dynamics as well as PI(4,5)P2 localisation. We also used a GFP-chimera of the well characterised PI(4,5)P2-binding pleckstrin homology domain of PLCδ1. This showed no difference in localisation upon OCRL1 depletion. As OCRL1 is highly enriched at the TGN, we fused the pleckstrin homology domain of PLCδ1 to a mutated pleckstrin homology domain of OSBP known to bind ARF1 at the TGN, to act as a coincidence detector for PI(4,5)P2 at the TGN. This construct also showed no reproducible effect of OCRL1 depletion. Secondly we tested the effect of loss of OCRL1 on cytosolic calcium levels. Using two phospholipase C (PLC) agonists, and a SERCA pump inhibitor, we found no consistent differences in calcium handling upon depletion of OCRL1. Thirdly, we have assessed the potential specialised role that OCRL1 has in polarised epithelial cells, which might relate to the clinical picture in Lowe Syndrome. We found that OCRL1 targets the tight junctions of immortalised lines and primary cells. Through co-immunoprecipitation, we found OCRL1 in complexes with the tight junction scaffold protein ZO-1. Most significantly, we found that depletion of OCRL1 in human polarised epithelial cell lines interfered with epithelial differentiation, reducing cell number and altering morphology, to produce large flat cells. We attribute this phenotype, stronger than any other so far described experimentally, to a defect in tight junction maturation.
|Title:||Study of the cell biological role of Lowe Syndrome protein OCRL1|
|Open access status:||An open access version is available from UCL Discovery|
|UCL classification:||UCL > School of Life and Medical Sciences > Faculty of Brain Sciences > Institute of Ophthalmology|
View download statistics for this item
Activity - last month
Activity - last 12 months
Archive Staff Only: edit this record